During herpes simplex virus type 1 (HSV 1) infection, the tegument protein VP22 is exported from infected cells to the nuclei of surrounding uninfected cells. These intercellular transport characteristics have prompted the exploitation of VP22 fusion proteins for cancer gene therapy, with the goal of maximizing the bystander effect. Since solid tumors contain hypoxic cell populations that are often refractive to therapy, for efficient targeting, it would be optimal if VP22 functioned even at reduced oxygen concentrations. In the present work, VP22 activity under hypoxic conditions was examined for the first time. Plasmid-transfected human glioma U87-MG and U373-MG cells expressing VP22 fused to the green fluorescent protein (GFP) showed protein export to untransfected cells under tumor oxygenation conditions (0-5% O 2 ). For suicide gene therapy, VP22 activity was demonstrated under hypoxia by coupling VP22 to the HSV thymidine kinase (HSVtk). In the presence of the prodrug ganciclovir, cell cultures expressing VP22-HSVtk showed a significant increase in toxicity compared with cells transfected with a construct containing HSVtk only, under all tested conditions. To allow effective suicide gene therapy and simultaneous visualization of therapeutic enzyme localization, a triple fusion protein GFP-HSVtk-VP22 was engineered. Functionality of all components was demonstrated under oxia and hypoxia. Gene Therapy (2005) 12, 974-979.
Introduction
Efficient delivery of therapeutic agents to the target site is one of the major obstacles in the development of successful gene therapy. Induction of a bystander effect, whereby the cytotoxic effects are extended to untransduced neighboring cells, has therefore become an important issue. To this end, attention has been drawn towards the herpes simplex virus type 1 (HSV 1) tegument protein VP22. In HSV-infected cells, VP22 can spread very efficiently via an ER/Golgi-independent pathway to surrounding uninfected cells, where it specifically accumulates in the nucleus. 1 These trafficking properties are preserved in numerous human cell types, even when VP22 is endogenously expressed fused to another protein such as the reporter green fluorescent protein (GFP). [1] [2] [3] Importantly, VP22-mediated protein export depends neither on gap junction-mediated communication nor on the expression of connexins, the major component of gap junctions. 4 This represents a significant advantage for use of VP22 in solid tumors, especially glioma, where cell-cell communication is often impaired. The therapeutic benefit of this 'biologically active' bystander effect for suicide gene therapy has been demonstrated by coupling VP22 to the HSV thymidine kinase (HSVtk) 4 and to cytosine deaminase (CD). 5 In the presence of the prodrugs ganciclovir (GCV) and 5-fluorocytosine respectively, expression of VP22-HSVtk and VP22-CD produced a significant increase in bystander killing in vitro and tumor regression in vivo, compared with the native proteins. Analogously, a VP22-p53 chimera retained its ability to colonize recipient nuclei and induced an increase of apoptosis 6 and tumor growth inhibition 7 in p53-negative human tumor cells. Solid human tumors have been shown to contain significant cell populations at oxygen concentrations below those seen in normal tissue. These hypoxic areas are often refractive to therapy, deleteriously effecting the outcome of chemotherapy, radiotherapy and surgery. [8] [9] [10] However, severe hypoxia is a physiological characteristic unique to solid tumors that can be targeted for selective gene therapy (for a recent review, see Greco et al 11 ). Therefore, for cancer gene therapy, it will be important for VP22 to function in hypoxic cells.
In the present work, VP22 activity was examined under a range of oxygenation conditions, reflective of those seen in solid tumors. Furthermore, as a tool for imaging protein expression and bystander activity in situ, for example, by whole-body optical imaging 12 or using a skin window chamber, 13 a triple fusion protein containing VP22, the reporter GFP and the suicide gene HSVtk was engineered. The GFP-HSVtk-VP22 triple fusion was tested for functionality under oxia and hypoxia.
Results and discussion
The trafficking properties of VP22 were tested in two human glioma cell lines, U87-MG cells, positive for connexin 43 expression and gap junction-mediated  communication, and U373-MG cells, connexins 43 and  32 and gap junction negative. 14,15 Lipid-mediated transfection with the plasmid pGFP, containing the reporter GFP under the control of the cytomegalovirus immediate-early (CMV IE) promoter, resulted in 10-15 and 5-10% GFP-positive U87-MG and U373-MG cells, respectively, as determined by fluorescence-activated cell sorting (FACS). Transient rather than stable transfectants were used, since temporal expression and lack of integration of the therapeutic gene are more likely to occur in vivo with current delivery systems such as liposomes and adenovirus vectors (reviewed in Greco et al 16 ) . When the cells expressed GFP fused to the C-terminal of VP22 from the same plasmid vector, these values increased by three-to five-fold under oxia (5% O 2 ; Figure 1 ). As anticipated, VP22-mediated protein export was common to both cell lines, regardless of gap junction activity. When viewed by fluorescence microscopy, monolayers of U87-MG and U373-MG cells appeared composed of single cells expressing VP22-GFP surrounded by several cells containing nuclear VP22-GFP (Figure 2a , b, e and f). Cells expressing GFP only showed a homogeneous fluorescence throughout the cell, while cells transfected with a construct containing VP22 only did not reveal any fluorescence (Figure 2c, d, g and h) . When cells were moved to hypoxia (0-1% O 2 ) immediately after transfection, VP22-mediated protein trafficking did not appear to be affected (Figure 1 ), as no statistically significant difference was observed between the VP22-mediated increase in GFP-positive cells under the different oxygen conditions tested. A similar pattern was observed when the cells were returned to the 5% O 2 incubator for reoxygenation after the hypoxic incubation ( Figure 1 ). This indicates that correct VP22 folding and transport does not require oxygen, in accordance with the observation that internalization of VP22 is an energyindependent process. 17 The use of VP22 as a cargo protein remains controversial, and its nuclear targeting properties have been 
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suggested to be an experimental artifact. In particular, trafficking of VP22-GFP has been observed to be dependent on the assay method, as some reports showed no spreading in unfixed cells. 17, 18 In one study, methanol fixation appeared to cause the nuclear import of VP22, which was otherwise only attached to the surface of the recipient cells. 17 Conversely, several reports showed efficient transport in living cells, 3, 19 regardless of the fixation method. 20 In our experiments, VP22-GFP spreading to the nuclei of acceptor cells was detected by fluorescence microscopy both in fixed and unfixed cells (Figure 2a, b, e and f) ; however, FACS analysis revealed an increase in the number of GFP-positive cells only after fixation with either 3% formaldehyde, 100% methanol or both (data not shown). This could be due to the fact that the level of protein in the recipient cells was below the level of detection in living cells, while fixation may have resulted in intracellular protein concentration. 2 Moreover, it has been reported that VP22-GFP export may depend on the transfection method. 5 We have also observed this when adopting different transfection agents and lipid/DNA ratios (data not shown). Thus, to overcome artifacts that may be related to GFP detection, we replaced VP22-GFP with a VP22-HSVtk fusion protein construct and tested it for experimental suicide gene therapy under oxia and hypoxia. Transfected cells were incubated with GCV under different oxygen concentrations, and cell growth was monitored by using an MTS-based growth inhibition assay ( Figure  3 ). Cells expressing VP22-HSVtk showed a significant increase in GCV-mediated toxicity compared with cells transfected with the HSVtk construct, under all tested conditions (P-values are indicated in Figure 3 ). For example, in U87-MG cells, characterized by a transfection efficiency of 10-15%, HSVtk/GCV gene therapy induced growth inhibition in B20% of the cells. The killing effect was extended by a further 20%, when the cells expressed HSVtk fused to VP22 (Figure 3a ). An additional increase in VP22-mediated bystander killing is likely to be observed by adopting three-dimensional tumor cell culture models, such as spheroids, which have proven to be a useful tool to assess experimental suicide gene therapy under oxic and hypoxic conditions. 21, 22 To allow effective suicide gene therapy and simultaneously achieve real-time visualization of therapeutic enzyme localization, delivery and spread, we engineered a triple fusion protein composed of GFP, a mutant version of HSVtk (HSVtkm, displaying higher affinity for GCV 23, 24 ) and VP22. U87-MG and U373-MG cells transfected with the pGFP-HSVtkm-VP22 plasmid, when viewed by fluorescence microscopy using a GFP-specific filter, displayed an intercellular trafficking pattern typical of VP22-GFP spread (Figure 4 ). Immunostaining coupled with direct GFP fluorescence followed by FACS showed that U87-MG cells transfected with pGFPHSVtkm-VP22 were positive for both GFP and VP22 (Figure 5c ) or GFP and HSVtkm (Figure 5f ). An identical pattern was observed in U373-MG cells (data not shown). FACS analysis was also employed to detect the trafficking ability of the GFP-HSVtkm-VP22. U87-MG and U373-MG cells transfected with pGFP-HSVtkm-VP22 showed a 3.8(70.4)-and a 8.0(71.1)-fold increase in GFP fluorescence, respectively, compared with pGFPtransfected cells. Finally, GFP-HSVtkm-VP22 was tested for experimental suicide gene therapy. As expected, the mutant HSVtkm was more effective than the wild-type HSVtk in converting GCV into a cytotoxin (compare Figures 3 and 6 ). Most importantly, compared with HSVtkm, expression of GFP-HSVtkm-VP22 resulted in a significant increase in GCV-mediated toxicity in both cell lines under oxia and hypoxia (P-values are in Figure 6 ). The triple fusion protein was at least as effective in inducing bystander killing as the double fusions VP22-HSVtkm and HSVtkm-VP22 ( Figure 6 ). In addition, VP22 activity did not appear to be affected whether fused to either the C-or the N-terminus of HSVtk ( Figure 6 ). This result confirms reported experiments using C-and the N-terminal fusion of VP22 with GFP 6 and HSVtk. 4 However, reports using the C-terminal fusions VP22-p53, 25 VP22-CD 5 and VP22-p27 20 showed either lack of VP22-mediated intercellular transport or loss of functionality of the fused protein. Correct folding of the fusion protein may be the critical issue in these cases, as the C-terminal extremity of VP22 is essential for intercellular trafficking, 26 and the transport function may be impaired by the folding induced by the fusion of certain proteins. 
Although much controversy has characterized the trafficking potential of VP22, the protein spread and the antitumor efficacy seen in several in vivo studies are nevertheless promising. It is shown here for the first time that VP22 is functional under hypoxic conditions characteristic of solid tumors and thus is amenable to gene therapy of cancer. Moreover, we have engineered a triple GFP-HSVtk-VP22 fusion vector that combines advantages of easy detection, suicide gene therapy and gap junction-independent intercellular transport. This 'biological' bystander effect may result in a significant therapeutic gain, especially in the treatment of malignancies such as glioma, characterized by poor intercellular communication, which are currently refractive to common treatment modalities.
Materials and methods

Cell culture
Human U87-MG and U373-MG glioma cells (European Collection of Cell Cultures, Salisbury, UK) were maintained in RPMI medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 mg/ml streptomycin (SigmaAldrich, St Louis, MO, USA), 2 mM L-glutamine (Invitrogen), and incubated in a humidified incubator at 371C in 5% O 2 :5% CO 2 :90% N 2 . Cells were routinely tested and found free of mycoplasma infection (PCR Mycoplasma Detection Set; Takara Bio Inc., Otsu, Japan).
Vector construction and cell transfection
To produce the pVP22-GFP construct, the VP22 openreading frame (ORF) was subcloned, using BamHI (all enzymes from MBI Fermentas, Hanover, MD, USA), from the pUL49ep plasmid 27 (from Dr J McLauchlan, University of Glasgow, Glasgow, UK), in-frame into pEGFPN1 (BD Biosciences, San Jose, CA, USA). To create pVP22-HSVtk, the GFP ORF was excised from pEGFPN3 VP22-mediated trafficking under hypoxia O Greco et al (BD Biosciences), replaced with the HSVtk ORF from ptk 28 using EcoRI and NotI, producing pHSVtk. Subsequently, the VP22 BamHI fragment from pUL49ep was cloned upstream into the in-frame BglII site. The HSVtk mutant30 (HSVtkm) gene was isolated from the plasmid clone pET23d:30 23 by PCR using specific terminal primers (containing EcoRI and XbaI restriction enzyme sites, respectively) and the Platinum Pfx DNA polymerase (Invitrogen). This PCR fragment was cloned into pCIneo (Promega, Madison, WI, USA) to produce pHSVtkm, and into pGFP 29 to produce a chimeric, inframe, GFP-HSVtkm ORF. Similarly, the VP22 gene was obtained by Pfx PCR from pVP22-HSVtk template and cloned into pGFP-HSVtkm using XbaI and NotI, creating pGFP-HSVtkm-VP22. pHSVtkm-VP22 was obtained by removing the GFP ORF from pGFP-HSVTKm-VP22 by digestion with EcoRI and NheI, followed by creating blunt ends using the DNA Polymerase I Large Klenow fragment and religation of the vector. The integrity of all plasmids was confirmed by DNA sequencing. Transient transfections were performed using TransIT (Mirus Corporation, Madison, WI, USA), according to the manufacturer's instructions.
Hypoxic conditions
For experiments under hypoxic conditions, cultures were manipulated in a 371C anaerobic glove cabinet (PlasLabs, Lansing, MI, USA) with 5% CO 2 :5% H 2 :90% N 2 and a palladium catalyst. Anaerobic conditions were monitored with BR55 anaerobic indicators (Oxoid Ltd, Basingstoke, UK). The cells were plated into O 2 -impermeable dishes (Permanox, Nalge Nunc International, Rochester, NY, USA), transfected in air and subsequently incubated in air-tight Plexiglas boxes flushed with a humidified gas mixture with 5% CO 2 and balance N 2 . Plastics and fluids were preincubated in the cabinet for about 1 week prior to use, to remove residual oxygen.
Immunodetection
Cells were fixed in 3% paraformaldehyde/PBS, followed by 100% methanol. Nonspecific binding was blocked by incubation in 5% FBS/1% Tween 20 (Fisher Scientific, Hannover Park, IL, USA)/PBS. The cells were incubated with anti-VP22 rabbit polyclonal sera (from Dr P O'Hare, Marie Curie Research Institute, Oxted, UK) or antiHSVtk rabbit polyclonal sera (from Dr W Summers, Yale University, New Haven, CT, USA) diluted 1:50, followed by exposure to phycoerythrin-conjugated goat antirabbit immunoglobulins (Molecular Probes, Eugene, OR, USA), diluted 1:40.
Flow cytometry
Cell fluorescence was detected by FACS on a Becton Dickinson FACScan (Franklin Lakes, NJ, USA). Data analysis were conducted using dedicated software (CELLQuest for Apple Macintosh; Becton Dickinson). Fluorescence was normalized to that of cells transfected with a plasmid where the transgene was controlled by the CMV IE promoter.
Cell growth inhibition assay
After transfection, cells were harvested, plated into 96-well plates (2000 cells/well; 8 wells/data point) with or without 50 mM GCV (Sigma-Aldrich) and incubated under different oxygen concentrations. After 24 h, the cells were returned to the 5% O 2 incubator and grown until control plate monolayers reached 90% confluence (4-6 days). Cell viability was assayed by using the CellTiter 96t AQ ueous (Promega) assay, according to the manufacturer's instructions. Briefly, the culture medium was supplemented with 3-(4,5-dimethylthiazol-2-yl)-5-(carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) and phenazine methosulfate (PMS), at the final concentrations of 166 mg/ml and 12.5 mM, respectively, and left to react for 2 h. The plates were agitated to ensure complete mixing and scanned on a Microplate Autoreader (Bio-Tek Instruments, Winooski, VT, USA) at 492 nm.
Statistical analysis
Significance tests were carried out on the data groups by using analysis of variance (ANOVA) followed by pair-wise comparison between specific groups (Student's t-test). Figure 6 GCV-mediated toxicity in cells expressing the GFP-HSVtkm-VP22 triple fusion. U87-MG (a) and U373-MG (b) cells were transfected and assayed for GCV-mediated toxicity as described in Figure 3 . Means7s.e.'s of at least three experiments are shown. Asterisks indicate statistically significant difference from pHSVtkm, **Po0.01; *Po0.05.
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